Thursday, June 30, 2016

Titan Medical CEO resigns as director following AGM vote

Titan Medical CEO resigns as director following AGM vote

June 23, 2016 by · Leave a Comment 

Tweet At the annual meeting of Titan Medical (TSX:TMD), shareholders voted against reelecting John Hargrove, CEO and chairman, as a director. Mr. Hargrove received 42% of votes cast in favor of reelection and 58% against. Following the meeting, Mr. Hargrove tendered his resignation as a director of Titan Medical in accordance with the company’s majority […]

Avivagen reports new livestock trials with OxC-beta

Avivagen reports new livestock trials with OxC-beta

June 20, 2016 by · Leave a Comment 

Tweet Avivagen (TSX-V:VIV) has provided results of four new trials of OxC-beta livestock as a feed additive for swine in the Philippines and Vietnam, and broiler poultry in the Philippines and Spain. In a new trial with the National Institute of Animal Sciences for Vietnam, the use of OxC-beta significantly improved the major commercial parameters […]

GeneNews resolves TSX, OSC issues

GeneNews resolves TSX, OSC issues

June 16, 2016 by · Leave a Comment 

Tweet GeneNews (TSX:GEN), by raising additional financings via a series of transactions over the past few weeks, and filing its full year 2015 and 2016 first quarter results, has successfully resolved both the Toronto Stock Exchange continued listing review and the management cease trade order granted by the Ontario Securities Commission in March. “The last […]

QLT and Aegerion Pharma to merge

QLT and Aegerion Pharma to merge

June 15, 2016 by · Leave a Comment 

Tweet QLT (NASDAQ:QLTI; TSX:QLT) and Aegerion Pharmaceuticals (NASDAQ:AEGR) have entered into a definitive merger agreement, with the resulting company to be renamed, Novelion Therapeutics. Under the accord, each outstanding share of Aegerion common stock will be exchanged for 1.0256 shares of QLT common stock. Assuming completion of the proposed merger by the end of the […]

ESSA Pharma takes unique approach to prostate cancer

ESSA Pharma takes unique approach to prostate cancer

June 7, 2016 by · Leave a Comment 

Tweet A marine sponge, Geodia lindgreni, native to Papua New Guinea may hold the key to a new approach in the treatment of prostrate cancer by ESSA Pharma (NASDAQ:EPIX; TSX:EPI). “Our scientific founders from the BC Cancer Agency and the University of British Columbia spent more than a decade conducting the basic biology research, identifying […]

Avivagen closes private placement

Avivagen closes private placement

June 3, 2016 by · Leave a Comment 

Tweet Avivagen (TSX-V:VIV) has completed a private placement of brokered and non-brokered components, selling 60 million units for gross proceeds of $3.6-million. Each unit consists of one common share and one-half of a warrant at a price of six cents a unit. Each whole warrant entitles the holder to acquire one common share of Avivagen […]

Delivra in technology licensing pact with Kalytera

Delivra in technology licensing pact with Kalytera

June 2, 2016 by · Leave a Comment 

Tweet Delivra (TSX-V:DVA) has entered into a technology licensing agreement with closely-held Kalytera Therapeutics, which is developing a portfolio of non-psychoactive cannabinoid and endocannabinoid-like medicines across a range of disease states, with an initial focus on bone health. Under the accord, Delivra will license its proprietary transdermal delivery technology to Kalytera for its exclusive use […]

Nobilis Health strategy gains media attention

Nobilis Health strategy gains media attention

May 26, 2016 by · Leave a Comment 

Tweet Nobilis Health (NYSE MKT:HLTH; TSX:NHC) VP of Corporate Development, Kolin Ozonian, has been interviewed by The Life Sciences Report about the company’s strategy of managing both acquisitions and internal growth at the same time. In the interview, Mr. Ozonian discusses how Nobilis is orchestrating the flow of new patients to its ambulatory surgical centers while […]

BioSyent signs distribution pact for two CV products

BioSyent signs distribution pact for two CV products

May 25, 2016 by · Leave a Comment 

Tweet BioSyent (TSX-V:RX; OTC:BIOYF) has signed an exclusive distribution agreement with a European partner for two new products in the cardiovascular therapeutic area for the Canadian market. The products have been approved in Europe and in certain other markets around the world and will be launched in Canada if approval is granted by Health Canada. […]

Delivra implementing U.S. expansion strategy for topical creams

Delivra implementing U.S. expansion strategy for topical creams

May 24, 2016 by · Leave a Comment 

Tweet The major initiative for Delivra (TSX-V:DVA) in 2016 is to introduce its flagship LivRelief topical pain and nerve creams to the U.S. market, initially through a U.S. web store and Amazon, and then through regional and national retailers, such as Walmart, Walgreens and CVS. “We are launching an aggressive digital campaign shortly, and later […]

Next Page »

Email Newsletters with Constant Contact
Google+